Remus Pharmaceuticals Limited

NSEI:REMUS Stock Report

Market Cap: ₹10.9b

Remus Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NSEI:REMUS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Mar 24Buy₹730,699Renosen Pharmaceuticals Private LimitedCompany125₹5,845.59
15 Mar 24Buy₹267,450Renosen Pharmaceuticals Private LimitedCompany50₹5,349.00
12 Mar 24Buy₹630,700Renosen Pharmaceuticals Private LimitedCompany125₹5,100.00
06 Mar 24Buy₹565,175Renosen Pharmaceuticals Private LimitedCompany100₹5,699.00
05 Mar 24Buy₹1,116,545Renosen Pharmaceuticals Private LimitedCompany200₹5,599.95
20 Feb 24Buy₹1,360,648Renosen Pharmaceuticals Private LimitedCompany200₹6,803.24
13 Feb 24Buy₹2,070,000Renosen Pharmaceuticals Private LimitedCompany300₹6,900.00
24 Jan 24Buy₹1,247,666Arpit ShahIndividual200₹6,248.53
24 Jan 24Buy₹307,499Renosen Pharmaceuticals Private LimitedCompany50₹6,149.98
20 Jan 24Buy₹158,750Arpit ShahIndividual25₹6,350.00
19 Jan 24Buy₹3,157,050Arpit ShahIndividual500₹6,314.10
18 Jan 24Buy₹3,596,673Renosen Pharmaceuticals Private LimitedCompany550₹6,625.40
12 Jan 24Buy₹2,061,375Renosen Pharmaceuticals Private LimitedCompany300₹6,871.25
03 Jan 24Buy₹2,952,000Arpit ShahIndividual400₹7,380.00
03 Jan 24Buy₹2,943,245Renosen Pharmaceuticals Private LimitedCompany400₹7,372.46
01 Jan 24Buy₹9,142,536Arpit ShahIndividual1,200₹7,618.78
01 Jan 24Buy₹7,576,350Renosen Pharmaceuticals Private LimitedCompany1,000₹7,608.36
28 Dec 23Buy₹7,998,345Renosen Pharmaceuticals Private LimitedCompany1,050₹7,779.96
26 Dec 23Buy₹7,620,000Arpit ShahIndividual1,000₹7,620.00
18 Dec 23Sell₹161,400Parag ShahIndividual25₹6,456.00
14 Dec 23Buy₹544,000Renosen Pharmaceuticals Private LimitedCompany100₹5,440.00
14 Dec 23Buy₹1,099,000Arpit ShahIndividual200₹5,495.00
13 Dec 23Buy₹1,657,623Arpit ShahIndividual300₹5,525.41
11 Dec 23Buy₹2,068,412Renosen Pharmaceuticals Private LimitedCompany375₹5,544.00
07 Dec 23Buy₹2,860,851Arpit ShahIndividual525₹5,449.24
07 Dec 23Buy₹2,606,076Renosen Pharmaceuticals Private LimitedCompany475₹5,499.00
06 Dec 23Buy₹1,228,275Renosen Pharmaceuticals Private LimitedCompany225₹5,459.00
04 Dec 23Buy₹2,777,750Roma ShahIndividual500₹5,555.50
01 Dec 23Buy₹2,781,975Roma ShahIndividual500₹5,563.95
25 Oct 23Buy₹6,458,270Renosen Pharmaceuticals Private LimitedCompany1,200₹5,395.70
28 Sep 23Buy₹12,063,440Renosen Pharmaceuticals Private LimitedCompany2,400₹5,088.00
27 Sep 23Buy₹10,399,055Roma ShahIndividual2,100₹5,099.00
26 Sep 23Buy₹10,648,090Arpit ShahIndividual2,200₹5,041.95
21 Sep 23Buy₹9,737,300Arpit ShahIndividual2,200₹4,461.00
08 Sep 23Buy₹4,320,400Balwant PurohitIndividual1,000₹4,320.40
08 Sep 23Buy₹1,288,095Swapnil ShahIndividual300₹4,293.65
07 Sep 23Buy₹2,673,695Vishrut PathakIndividual600₹4,456.16
06 Sep 23Buy₹435,000Renosen Pharmaceuticals Private LimitedCompany100₹4,350.00
04 Sep 23Buy₹4,182,085Renosen Pharmaceuticals Private LimitedCompany1,000₹4,275.98
01 Sep 23Buy₹4,289,200Swapnil ShahIndividual1,000₹4,347.00
01 Sep 23Buy₹4,211,965Anar ShahIndividual1,000₹4,269.98
22 Aug 23Buy₹2,219,700Vishrut PathakIndividual500₹4,590.00
18 Aug 23Buy₹464,000Vishrut PathakIndividual100₹4,640.00
16 Aug 23Buy₹940,000Anjali ShahIndividual200₹4,700.00
16 Aug 23Buy₹950,000Parag ShahIndividual200₹4,750.00
28 Jul 23Buy₹386,600Vishrut PathakIndividual100₹3,866.00
27 Jul 23Buy₹1,875,000Vishrut PathakIndividual500₹3,750.00
25 Jul 23Buy₹4,894,195Swapnil ShahIndividual1,500₹3,280.00
25 Jul 23Buy₹3,033,925Vishrut PathakIndividual900₹3,371.03
17 Jul 23Buy₹2,143,260Swapnil ShahIndividual600₹3,645.00
14 Jul 23Buy₹731,500Vishrut PathakIndividual200₹3,657.50
13 Jul 23Buy₹13,200,655Swapnil ShahIndividual3,600₹3,802.29
12 Jul 23Buy₹750,000Vishrut PathakIndividual200₹3,750.00
11 Jul 23Buy₹1,431,995Swapnil ShahIndividual400₹3,579.99
07 Jul 23Buy₹3,685,000Deval PatelIndividual1,000₹3,685.00
07 Jul 23Buy₹3,821,000Swapnil ShahIndividual2,000₹3,862.40
07 Jul 23Buy₹3,434,685Vishrut PathakIndividual900₹3,887.00
15 Jun 23Buy₹480,000Swapnil ShahIndividual200₹2,400.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of REMUS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies10,3250.701%
Individual Insiders555,92537.7%
General Public906,75061.6%

Dilution of Shares: REMUS only recently listed within the past 12 months

Top Shareholders

Top 11 shareholders own 38.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.6%
Arpit Shah
258,750₹1.9b0.91%no data
17.2%
Roma Shah
253,100₹1.9b0.4%no data
1.09%
Rekha Kumar
16,000₹117.9m0%no data
1%
Swapnil Shah
14,700₹108.3m0%no data
0.7%
Renosen Pharmaceuticals Private Limited
10,325₹76.1m49.1%no data
0.27%
Vishrut Pathak
4,000₹29.5m0%no data
0.24%
Deval Patel
3,500₹25.8m0%no data
0.18%
Parag Shah
2,675₹19.7m-0.93%no data
0.14%
Balwant Purohit
2,000₹14.7m0%no data
0.068%
Anar Shah
1,000₹7.4m0%no data
0.014%
Anjali Shah
200₹1.5m0%no data
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.